November 15th, 2026Kidney Compass: FIND-CKD Finerenone Data in FSGS and Treatment SequencingHiddo Heerspink, PharmD, PhD, joins Brendon Neuen, MBBS, PhD, and Shikha Wadhwani, MD, MS, to unpack finerenone’s FIND-CKD data in FSGS.Read more
November 15th, 2026Kidney Compass: GFR Slope and Hierarchical Composite Endpoints in Glomerular DiseaseLesley Inker, MD, MS, joins Brendon Neuen, MBBS, PhD, to unpack GFR slope and hierarchical composite endpoints in glomerular disease trials.Read more
November 14th, 2026Kidney Compass: Platform Trials in IgA Nephropathy and Glomerular DiseaseSuceena Alexander, MD, joins Brendon Neuen, MBBS, PhD, and Shikha Wadhwani, MD, MS, to discuss platform trial design in IgA nephropathy and beyond.Read more
November 17th, 2026Don't Miss a Beat: How Prediction Markets Could Threaten Clinical Trial IntegrityAnkeet Bhatt, MD, MBA, ScM, explains how prediction markets could threaten clinical trial integrity by undermining participant retention and trust.Read more
November 16th, 2026Diabetes Dialogue: OPTIMAL-DIABETES, Survodutide, and Orforglipron at AHA 2026Diana Isaacs, PharmD, and Natalie Bellini, DNP, review OPTIMAL-DIABETES, SYNCHRONIZE-CVOT, and ATTAIN-OSA data from AHA 2026.Read more
November 16th, 2026Diabetes Dialogue: Tubeless Mobi Clearance, CGM Choice, and Eversense FreedomDiana Isaacs, PharmD, and Natalie Bellini, DNP, discuss tubeless Mobi's FDA clearance, CVS Caremark's CGM formulary shift, and a transmitter-free implant.Read more
November 14th, 2026FDA Approves Obinutuzumab (Gazyva) for Primary Membranous NephropathyApproval of obinutuzumab for adults with PMN follows MAJESTY, where 37% vs 6% achieved complete remission at week 104 vs tacrolimus.Read more
November 13th, 2026ABCs in Dermatology: Rethinking Corticosteroid Stewardship in Chronic Hand EczemaExperts outline when to stop cycling topical steroids in chronic hand eczema and where topical delgocitinib now fits.Read more